NCT05504265View on ClinicalTrials.gov

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

September 30, 2025

Study Completion Date

December 20, 2025

Conditions
Esophageal CancerPerioperative AnalgesiaNSAIDsOpioidPatient-controlled Analgesia
Interventions
DRUG

Preemptive flurbiprofen axetil

50mg once，30min before induction anesthesia

DRUG

Postoperative flurbiprofen axetil

50mg bid

DEVICE

Patient-controlled analgesia pump

Sufentanil 2.5 μg/kg+ondansetron 8mg, prepared to 100ml normal saline; background dose: 2 ml/h, single press analgesic pump injection volume: 0.5 ml, locking time: 15 min.

Trial Locations (1)

Unknown

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER